Patents by Inventor James BRIEN

James BRIEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF BUNYAVIRIDAE AND USES THEREOF
    Publication number: 20250009686
    Abstract: The present disclosure provides inhibitors of bunyavirus of the formula: wherein the variables are defined herein.
    Type: Application
    Filed: May 13, 2024
    Publication date: January 9, 2025
    Applicants: Saint Louis University, National and Kapodistrian University of Athens
    Inventors: John Edwin TAVIS, Grigoris ZOIDIS, Amelia PINTO, James BRIEN
  • Inhibitors of Bunyaviridae and uses thereof
    Patent number: 12121500
    Abstract: The present disclosure provides inhibitors of bunyavirus of the formula: wherein the variables are defined herein. These inhibitors may be used to treat an infection of Rift Valley phlebovirus, hantavirus, and La Crosse virus, or Crimean-Congo Hemorrhagic fever.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: October 22, 2024
    Assignees: Saint Louis University, Research Foundation of the City University of New York
    Inventors: John Edwin Tavis, Amelia Pinto, James Brien, Ryan Murelli
  • INHIBITORS OF BUNYAVIRIDAE AND USES THEREOF
    Publication number: 20210393548
    Abstract: The present disclosure provides inhibitors of bunyavirus of the formula: wherein the variables are defined herein.
    Type: Application
    Filed: May 12, 2021
    Publication date: December 23, 2021
    Applicants: Saint Louis University, Research Foundation of The City University of New York, National and Kapodistrian University of Athens
    Inventors: John Edwin TAVIS, Grigoris ZOIDIS, Amelia PINTO, James BRIEN, Ryan MURELLI
  • TREATMENTS FOR ZIKA VIRUS INFECTION
    Publication number: 20210353564
    Abstract: The present disclosure is directed to methods of treating Zika virus infections using selective estrogen receptor modulators (SERMs), such as Tamoxifen, or a compound selected from CALP-1, A7, PMA, Chelerythrine, PHTPP, Tariquidar or S-Equol.
    Type: Application
    Filed: October 28, 2019
    Publication date: November 18, 2021
    Applicant: Saint Louis University
    Inventors: Christopher ARNATT, James BRIEN, Amelia PINTO